Obeticholic acid treatment of mice to promote fertilization and reproduction
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obeticholic acid treatment of mice to promote fertilization and reproduction
Authors
Keywords
-
Journal
ZYGOTE
Volume -, Issue -, Pages 1-10
Publisher
Cambridge University Press (CUP)
Online
2023-09-01
DOI
10.1017/s0967199423000400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms & Molecules: What are the treatment targets for PBC?
- (2022) Marlyn J Mayo HEPATOLOGY
- Biosolids: The Trojan horse or the beautiful Helen for soil fertilization?
- (2022) A.E. Kanteraki et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Integrated organic and inorganic fertilization and reduced irrigation altered prokaryotic microbial community and diversity in different compartments of wheat root zone contributing to improved nitrogen uptake and wheat yield
- (2022) Chao Wang et al. SCIENCE OF THE TOTAL ENVIRONMENT
- What is missing to advance foliar fertilization using nanotechnology?
- (2022) Søren Husted et al. TRENDS IN PLANT SCIENCE
- Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
- (2022) Kuei-Chuan Lee et al. Clinical and Molecular Hepatology
- Obeticholic acid and hepatic bile acids: Excellent study faulty conclusion
- (2021) Norman B. Javitt JOURNAL OF HEPATOLOGY
- Influences of irrigation and fertilization on soil N cycle and losses from wheat–maize cropping system in northern China
- (2021) Xin Zhang et al. ENVIRONMENTAL POLLUTION
- Obeticholic Acid Inhibits Anxiety via Alleviating Gut Microbiota-Mediated Microglia Accumulation in the Brain of High-Fat High-Sugar Diet Mice
- (2021) Li Wu et al. Nutrients
- A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage
- (2021) Suling Huang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Obeticholic acid ameliorates Valproic acid-induced Hepatic Steatosis and Oxidative Stress
- (2020) Zhibo Gai et al. MOLECULAR PHARMACOLOGY
- Obeticholic acid improves fetal bile acid profile in a mouse model of gestational hypercholanemia
- (2020) Vanessa Pataia et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Obeticholic acid ameliorates hepatorenal syndrome in ascitic cirrhotic rats by down-regulating the renal 8-iso-PGF2α-activated COX-TXA2 pathway
- (2020) Yu-Lien Tsai et al. CLINICAL SCIENCE
- The protective effect of obeticholic acid on lipopolysaccharide-induced disorder of maternal bile acid metabolism in pregnant mice
- (2020) Cheng Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice
- (2019) Hongkui Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Analysis of exposure margins in developmental toxicity studies for detection of human teratogens
- (2019) Paul A. Andrews et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Post‐ejaculatory modifications to sperm (PEMS)
- (2019) Scott Pitnick et al. BIOLOGICAL REVIEWS
- Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice
- (2019) Wei Chen et al. Oxidative Medicine and Cellular Longevity
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities
- (2019) Aliya F. Gulamhusein et al. Nature Reviews Gastroenterology & Hepatology
- Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
- (2018) O. Erice et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines
- (2018) Gideon M Hirschfield et al. GUT
- Prostaglandin E2 involvement in mammalian female fertility: ovulation, fertilization, embryo development and early implantation
- (2018) Jean Damascene Niringiyumukiza et al. Reproductive Biology and Endocrinology
- Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches
- (2018) Antonella Borrelli et al. Redox Biology
- Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
- (2018) Jiyu Zhou et al. Acta Pharmaceutica Sinica B
- Developmental and reproductive toxicological evaluation of arachidonic acid (ARA)-Rich oil and docosahexaenoic acid (DHA)-Rich oil
- (2017) Michael C. Falk et al. FOOD AND CHEMICAL TOXICOLOGY
- Importance of sperm morphology during their transport and fertilization in mammals
- (2016) FranciscoA García-Vázquez et al. ASIAN JOURNAL OF ANDROLOGY
- Obeticholic Acid: First Global Approval
- (2016) A. Markham et al. DRUGS
- Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity
- (2016) Yuan-Hua Chen et al. JOURNAL OF IMMUNOLOGY
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice
- (2016) Fahrettin Haczeyni et al. Obesity
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Hit or Miss: Fertilization Outcomes of Natural Inseminations by Japanese Quail
- (2015) Elizabeth Adkins-Regan PLoS One
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Phenotyping male infertility in the mouse: how to get the most out of a 'non-performer'
- (2009) C. L. Borg et al. HUMAN REPRODUCTION UPDATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started